News

The anti-malaria medication artesunate could be a potential treatment of Sjögren’s syndrome, a study suggested. In mouse and cellular models, artesunate showed an ability to inhibit inflammatory T-helper 17 (Th17) cells and ease Sjögren’s symptoms. The study, “Artesunate suppresses Th17 response via inhibiting IRF4- mediated glycolysis…

Memory complaints in people with primary Sjögren’s syndrome are linked to global cognitive impairment — problems affecting not only memory but also other mental faculties, according to data from a small study. While researchers noted that “associated psychiatric and sleep disorders greatly interfere” with cognition in Sjögren’s patients, they…

Higher-than-normal blood levels of uric acid, a body waste product, significantly raise the risk of hypertension among people with primary Sjögren’s syndrome (pSS), a study found. Findings suggest that monitoring uric acid levels may be one way to manage hypertension, or high blood pressure, to avoid cardiovascular problems arising later…

Self-targeting antibodies typically associated with a scarring disease called scleroderma are commonly found in people with Sjögren’s syndrome and may be useful in a diagnostic workup of those who have unexplained dryness of the eyes and mouth. That’s according to a study published in Seminars in Arthritis and Rheumatism…

Alterations to immune dendritic cells in the eyes of people with Sjögren’s syndrome were associated with both bodywide and eye-related disease severity, a study reported. Using a non-invasive specialized microscope to examine these immune cells on the surface of the eyes might be an objective way of evaluating disease…